Anna Maria Gerdina Pasmooij

Utrecht University

Netherlands

Research Interests

Explore related searches

Professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Collaborators (5)

Manuela Joore

University of Maastricht

NETHERLANDS

View details

Jan Kottner

Prof

Charité - Universitätsmedizin Berlin

GERMANY

View details

Anneliene Jonker

University of Twente

NETHERLANDS

View details

Ralf Herold

Head of Regulatory science and Academia workstream (ad interim)

NETHERLANDS

View details

Lourens Bloem

Utrecht University

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anna Maria Gerdina Pasmooij

Research Interests

Explore related searches

Contact this professor

Articles (10)

From roadmap to a sustainable end-to-end individualized therapy pathway

Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of European studies published up to 22 January 2024

Revising EU pharmaceutical legislation: will it foster drug repurposing?

Stimulating development of innovative medicines in the European Union: does a new definition for unmet medical need add value?

A new European platform for advancing regulatory science research

Learning from European regulator-initiated studies for regulatory decision making

The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap

Feasibility of disease terminology systems for mapping orphan conditions and therapeutic indications of designated orphan medicines in the European Union

Towards a roadmap for COSEB: the next steps in harmonization of outcomes for epidermolysis bullosa

Environmental risk assessment in the EU regulation of medicines for human use: an analysis of stakeholder perspectives on its current and future role

Collaborators (5)

Manuela Joore

Jan Kottner

Anneliene Jonker

Ralf Herold

Lourens Bloem

Make your next move.